GLP-1 drugs are 36% more effective than aspirin in reducing colorectal cancer risk, with fewer side effects like acute kidney injury and gastrointestinal bleeding. Diarrhea is a more common side ...

Newcastle University researchers discover exercise rapidly alters blood chemistry to support DNA repair in colon cancer cells ...

Ozempic and Wegovy might help people avoid colon cancer as well as promote weight loss or control diabetes, a new study says.

Many people associate colon cancer with old age, but that’s not the case anymore. New research is shedding light on a warning ...

Colorectal cancer, more popularly known as colon cancer, is one of the most common types of cancer in both men and women around the world. It’s a type of cancer that develops in the tissues of the ...

Regular physical activity—especially walking—can significantly reduce fatigue among people with colon cancer, a new study ...

Bowel cancer rates have been rising in people under 55 for years. But scientists have yet to determine the reason.

Colorectal cancer is the third most commonly diagnosed cancer and the third leading cause of cancer deaths, as reported by the American Cancer Society. The number of cases among individuals under 55 ...

In a recent small study published in the International Journal of Cancer, researchers found that a single, brief bout of ...

A recent study revealed that GLP-1 drugs, Ozempic and Wegovy, primarily used for diabetes and weight loss, may assist in ...

Taking aspirin on a daily basis protects against the recurrence of colon cancer, a new study found. People who took aspirin every day for three years had a 55% reduced risk of colorectal cancer tumors ...